FMC Corporation expands novel fluindapyr fungicide technology to EMEA region
FMC Corporation (NYSE: FMC) has received regulatory approval for Tremisia® fungicide in Ukraine, marking the first introduction of its fluindapyr technology in the EMEA region. The approval covers applications for oilseed rape, sunflower, and wheat across more than 10 million hectares of Ukrainian farmland.
Tremisia® fungicide combines FMC's proprietary fluindapyr molecule with flutriafol, providing a dual mode of action that targets diseases including Alternaria and Sclerotinia in sunflower, and Septoria and rust in wheat. The product has already been successfully commercialized in Argentina, Brazil, Mexico, Paraguay, South Korea, and the United States, with conditional approval in the Philippines.
The company plans to expand the availability of fluindapyr-based products to Bolivia, Chile, Colombia, Honduras, and India, pending regulatory approvals.
FMC Corporation (NYSE: FMC) ha ottenuto l'approvazione normativa per il fungicida Tremisia® in Ucraina, segnando la prima introduzione della sua tecnologia fluindapyr nella regione EMEA. L'approvazione riguarda le applicazioni su colza, girasole e grano per oltre 10 milioni di ettari di terreni agricoli ucraini.
Il fungicida Tremisia® combina la molecola proprietaria fluindapyr di FMC con il flutriafol, offrendo un duplice meccanismo d'azione che combatte malattie come Alternaria e Sclerotinia nel girasole, e Septoria e ruggine nel grano. Il prodotto è già stato commercializzato con successo in Argentina, Brasile, Messico, Paraguay, Corea del Sud e Stati Uniti, con approvazione condizionale nelle Filippine.
L'azienda prevede di estendere la disponibilità di prodotti a base di fluindapyr a Bolivia, Cile, Colombia, Honduras e India, in attesa delle approvazioni normative.
FMC Corporation (NYSE: FMC) ha recibido la aprobación regulatoria para el fungicida Tremisia® en Ucrania, marcando la primera introducción de su tecnología fluindapyr en la región EMEA. La aprobación cubre aplicaciones para colza, girasol y trigo en más de 10 millones de hectáreas de tierras agrícolas ucranianas.
El fungicida Tremisia® combina la molécula patentada fluindapyr de FMC con flutriafol, proporcionando un modo de acción dual que combate enfermedades como Alternaria y Sclerotinia en girasol, y Septoria y roya en trigo. El producto ya ha sido comercializado con éxito en Argentina, Brasil, México, Paraguay, Corea del Sur y Estados Unidos, con aprobación condicional en Filipinas.
La compañía planea ampliar la disponibilidad de productos basados en fluindapyr a Bolivia, Chile, Colombia, Honduras e India, pendiente de aprobaciones regulatorias.
FMC Corporation (NYSE: FMC)는 우크라이나에서 Tremisia® 살균제에 대한 규제 승인을 받았으며, 이는 EMEA 지역에서 플루인다피르 기술이 처음 도입된 사례입니다. 승인 범위는 우크라이나 농지 1,000만 헥타르 이상에서 유채, 해바라기, 밀에 적용됩니다.
Tremisia® 살균제는 FMC의 독자적인 플루인다피르 분자와 플루트리아폴을 결합하여 해바라기의 Alternaria 및 Sclerotinia, 밀의 Septoria 및 녹병 등 질병을 동시에 방제하는 이중 작용 방식을 제공합니다. 이 제품은 이미 아르헨티나, 브라질, 멕시코, 파라과이, 한국, 미국에서 성공적으로 상용화되었으며, 필리핀에서는 조건부 승인을 받았습니다.
회사는 규제 승인 대기 중인 볼리비아, 칠레, 콜롬비아, 온두라스, 인도로 플루인다피르 기반 제품의 공급을 확대할 계획입니다.
FMC Corporation (NYSE: FMC) a obtenu l'approbation réglementaire pour le fongicide Tremisia® en Ukraine, marquant la première introduction de sa technologie fluindapyr dans la région EMEA. L'approbation couvre les applications pour le colza, le tournesol et le blé sur plus de 10 millions d'hectares de terres agricoles ukrainiennes.
Le fongicide Tremisia® combine la molécule fluindapyr propriétaire de FMC avec le flutriafol, offrant un double mode d'action ciblant des maladies telles qu'Alternaria et Sclérotinia sur le tournesol, ainsi que Septoria et la rouille sur le blé. Le produit a déjà été commercialisé avec succès en Argentine, au Brésil, au Mexique, au Paraguay, en Corée du Sud et aux États-Unis, avec une approbation conditionnelle aux Philippines.
L'entreprise prévoit d'étendre la disponibilité des produits à base de fluindapyr en Bolivie, au Chili, en Colombie, au Honduras et en Inde, sous réserve des approbations réglementaires.
FMC Corporation (NYSE: FMC) hat die behördliche Zulassung für das Tremisia® Fungizid in der Ukraine erhalten, was die erste Einführung ihrer Fluindapyr-Technologie in der EMEA-Region markiert. Die Zulassung umfasst Anwendungen für Raps, Sonnenblumen und Weizen auf mehr als 10 Millionen Hektar ukrainischer Ackerflächen.
Das Tremisia® Fungizid kombiniert die firmeneigene Fluindapyr-Molekül von FMC mit Flutriafol und bietet einen dualen Wirkmechanismus, der Krankheiten wie Alternaria und Sclerotinia bei Sonnenblumen sowie Septoria und Rost bei Weizen bekämpft. Das Produkt wurde bereits erfolgreich in Argentinien, Brasilien, Mexiko, Paraguay, Südkorea und den USA kommerzialisiert und hat eine bedingte Zulassung auf den Philippinen.
Das Unternehmen plant, die Verfügbarkeit von Fluindapyr-basierten Produkten nach Bolivien, Chile, Kolumbien, Honduras und Indien auszuweiten, vorbehaltlich behördlicher Genehmigungen.
- First approval of fluindapyr technology in EMEA region
- Coverage for over 10 million hectares of Ukrainian farmland
- Dual mode of action technology combining fluindapyr with flutriafol
- Successful commercialization already achieved in six countries
- Planned expansion into five additional markets pending approvals
- None.
Insights
FMC's fluindapyr fungicide approval in Ukraine expands global reach with advanced crop protection technology in major agricultural market.
FMC's registration of Tremisia® fungicide in Ukraine represents a significant market expansion for their novel fluindapyr technology into the EMEA region. This approval targets three major crops - oilseed rape, sunflower, and wheat - covering over 10 million hectares of Ukrainian farmland. This is strategically important as Ukraine ranks among the world's largest exporters of these crops.
The dual-action formulation combining proprietary fluindapyr with flutriafol creates a superior disease management tool. This technology addresses critical crop diseases including Alternaria and Sclerotinia in sunflower, and Septoria and rust in wheat - all economically significant pathogens that can substantially reduce yields when uncontrolled.
From a technological perspective, this represents the continued global rollout of FMC's fluindapyr platform, which has already seen success in major agricultural markets across South America, North America, and parts of Asia. The company has secured conditional approval in the Philippines and anticipates launches in additional countries, demonstrating steady regulatory progress for this proprietary molecule.
For Ukrainian agriculture, this introduction fills a critical disease management gap in intensive cropping systems where pathogen pressure threatens productivity. The approval solidifies FMC's position in providing innovative crop protection solutions to major global agricultural markets.
Tremisia® fungicide receives registration in
"The registration advances the commercialization of FMC's novel fluindapyr fungicide technology," said Sebastià Pons, vice president, president of FMC EMEA. "
Tremisia® fungicide combines FMC's proprietary fluindapyr molecule with flutriafol, delivering a dual mode of action to help maintain a healthy crop for an extended period. This fungicide targets a broad spectrum of economically significant diseases, including Alternaria and Sclerotinia in sunflower, and Septoria and rust in wheat.
"This registration fills an important gap in disease management options for Ukrainian growers, providing a high-performance tool to protect their crops from devastating disease," said Nataliia Savchenko, FMC Ukraine country leader. "Disease pressures pose ongoing challenges to crop productivity in
The
About FMC
FMC Corporation is a global agricultural sciences company dedicated to helping growers produce food, feed, fiber and fuel for an expanding world population while adapting to a changing environment. FMC's innovative crop protection solutions – including biologicals, crop nutrition, digital and precision agriculture – enable growers and crop advisers to address their toughest challenges economically while protecting the environment. FMC is committed to discovering new herbicide, insecticide and fungicide active ingredients, product formulations and pioneering technologies that are consistently better for the planet. Visit fmc.com to learn more and follow us on LinkedIn®.
Tremisia is a trademark of FMC Corporation and/or an affiliate. Always read and follow all label directions, restrictions and precautions for use. Products listed here may not be registered for sale or use in all states, countries or jurisdictions.
Statement under the Safe Harbor Provisions of the Private Securities Litigation Reform Act of 1995: FMC and its representatives may from time to time make written or oral statements that are "forward-looking" and provide other than historical information, including statements contained in this press release, in FMC's other filings with the SEC, and in presentations, reports or letters to FMC stockholders.
In some cases, FMC has identified these forward-looking statements by such words or phrases as "outlook", "will likely result," "is confident that," "expect," "expects," "should," "could," "may," "will continue to," "believe," "believes," "anticipates," "predicts," "forecasts," "estimates," "projects," "potential," "intends" or similar expressions identifying "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, including the negative of those words or phrases. Such forward-looking statements are based on our current views and assumptions regarding future events, future business conditions and the outlook for the company based on currently available information. The forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause actual results to be materially different from any results, levels of activity, performance or achievements expressed or implied by any forward-looking statement. These statements are qualified by reference to the risk factors included in Part I, Item 1A of our Annual Report on Form 10-K for the year ended December 31, 2024 (the "2024 Form 10-K"), the section captioned "Forward-Looking Information" in Part II of the 2024 Form 10-K and to similar risk factors and cautionary statements in all other reports and forms filed with the Securities and Exchange Commission ("SEC"). We wish to caution readers not to place undue reliance on any such forward-looking statements, which speak only as of the date made. Forward-looking statements are qualified in their entirety by the above cautionary statement.
We specifically decline to undertake any obligation, and specifically disclaims any duty, to publicly update or revise any forward-looking statements that have been made to reflect events or circumstances after the date of such statements or to reflect the occurrence of anticipated or unanticipated events, except as may be required by law.
View original content to download multimedia:https://www.prnewswire.com/news-releases/fmc-corporation-expands-novel-fluindapyr-fungicide-technology-to-emea-region-302494863.html
SOURCE FMC Corporation
FAQ
What is FMC's new Tremisia® fungicide approved for in Ukraine?
How does FMC's Tremisia® fungicide work?
Which countries already have FMC's fluindapyr-based products?
Where is FMC planning to launch fluindapyr-based products next?
Why is the Ukraine market important for FMC's Tremisia® fungicide?
